ArticleFrontiers in pharmacology2019

Topical Application of KAJD Attenuates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis Symptoms Through Regulation of IgE and MAPK Pathways in BALB/C Mice and Several Immune Cell Types.

Se Hyang Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.